Ranbaxy Settles With FDA, Sets Aside $500M For DOJ Probe
Generic drug maker Ranbaxy Laboratories Ltd. said Tuesday it has settled with the U.S. Food and Drug Administration and set aside $500 million to resolve any liability arising from a separate...To view the full article, register now.
Already a subscriber? Click here to view full article